About Us


Isogenica's advanced synthetic antibody libraries and display technologies enable and accelerate our partners' therapeutic antibody discovery programmes.  


Isogenica was originally launched to develop and operate its proprietary cell-free, DNA-based display technology, CIS display, as a platform for the discovery of polypeptide biologics.


Following the acquisition and development of further technologies, including the Colibra™ DNA library building platform, we now offer opportunities for discovery partnerships with access to our skills and tools, including next-generation, best-in-class antibody libraries such as our camelid VHH (llamdA™), Fab fragment and human scFv (Xab™) libraries.


These libraries are available for license and screening partnerships which, together with our expertise in the screening of displayed peptide and scaffold libraries, can facilitate your biologics discovery needs.

llama vhh